Keywords: Roche, Pegasys, Hepatitis C, Children, EMA

Roche's Pegasys gets EU backing for chronic hepatitis C in children aged five years and older

Article | 18 March 2013

Print This

The European Medicines Agency has expanded the approval of Swiss drug major Roche’s (ROG: SIX) Pegasys (peginterferon alfa-2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in